News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Microbix Biosystems Inc. Licenses its Animal Reproduction Technology in China
June 27, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, June 27 /CNW/ - Toronto-based Microbix Biosystems Inc. (TSX:MBX) announced today that it has entered into an agreement to license its proprietary Semen Sexing Technology(TM) (SST) to a major commercial breeder in China.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
December 11, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
December 11, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact
December 9, 2025
·
2 min read
·
Tristan Manalac
China
With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned
December 9, 2025
·
3 min read
·
Annalee Armstrong